EFL

Cohort Year: 2021-2022

Tracks: Life Sciences

VISIT WEBSITE

OncoPrecision

OncoPrecision is developing Patient Micro-Avatars (PMAs) to replicate cancer patients' disease for ex-vivo screening to improve therapeutic response and drug development.